ITM2B and ITM2B amyloidosis: Furthermore, human genetic mutations which result in longer ITM2B protein C-terminal (and which increase the size and fibrillogenicity of the secreted peptide), are associated with two well-characterized neurogenerative diseases, familial British dementia and familial Danish dementia (40–42, 46–49).